We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

91 hedge funds and large institutions have $838M invested in IDEAYA Biosciences in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

171% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 17

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

57% more capital invested

Capital invested by funds: $533M → $838M (+$305M)

8.4% more ownership

Funds ownership: 77.19%85.59% (+8.4%)

8% more funds holding

Funds holding: 8491 (+7)

Holders
91
Holders Change
+7
Holders Change %
+8.33%
% of All Funds
1.59%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.11%
New
15
Increased
46
Reduced
17
Closed
8
Calls
$1.39M
Puts
Net Calls
+$1.39M
Net Calls Change
+$1.38M
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
26
ACT Capital Management
Pennsylvania
$4.42M +$2.44M +104,300 +151%
WP
27
Woodline Partners
California
$3.68M -$2.16M -92,316 -39%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$3.57M +$3.27M +139,950 New
N
29
Nuveen
North Carolina
$3.35M +$211K +9,025 +8%
VOYA Investment Management
30
VOYA Investment Management
Georgia
$3.02M +$2.51M +107,570 +974%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.81M +$746K +31,957 +41%
IBT
32
International Biotechnology Trust
United Kingdom
$2.78M +$2.55M +109,000 New
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$2.34M +$2.14M +91,690 New
Massachusetts Financial Services
34
Massachusetts Financial Services
Massachusetts
$2.3M +$495K +21,203 +31%
AllianceBernstein
35
AllianceBernstein
Tennessee
$2.19M
Charles Schwab
36
Charles Schwab
California
$2.12M +$410K +17,549 +27%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$1.7M +$205K +8,800 +15%
Goldman Sachs
38
Goldman Sachs
New York
$1.42M +$430K +18,410 +49%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$1.42M +$1.31M +56,310 New
JAMONY
40
Jacob Asset Management of New York
California
$1.39M +$67.1K +2,875 +6%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$1.34M -$1.93M -82,800 -61%
UBS Group
42
UBS Group
Switzerland
$1.13M +$494K +21,160 +91%
Ensign Peak Advisors
43
Ensign Peak Advisors
Utah
$941K
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$899K +$138K +5,889 +20%
Rafferty Asset Management
45
Rafferty Asset Management
New York
$802K +$735K +31,475 New
Renaissance Technologies
46
Renaissance Technologies
New York
$755K -$911K -39,000 -57%
Morgan Stanley
47
Morgan Stanley
New York
$698K +$370K +15,825 +137%
Citigroup
48
Citigroup
New York
$643K +$511K +21,894 +657%
JP Morgan Chase
49
JP Morgan Chase
New York
$632K +$115K +4,945 +25%
PAM
50
Panagora Asset Management
Massachusetts
$627K +$560K +23,996 +3,902%

IDYA Hedge Fund Activity: Q3 2021 in Review

91 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2021, worth a combined $838M — up 57% from $533M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IDYA positions and 8 closed out — a net gain of 7 holders — while 46 added to existing stakes and 17 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $41.4M. The largest seller was 5AM Venture Management, cutting an estimated $9.34M.

  • 91 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2021, up from 84 in Q2 2021.
  • Funds reported $838M of IDEAYA Biosciences stock for Q3 2021, up 57% quarter-over-quarter.
  • 15 funds opened new IDEAYA Biosciences positions in Q3 2021 and 8 closed out, a net change of +7 holders.
  • The largest IDEAYA Biosciences buyer in Q3 2021 was Logos Global Management, an estimated $41.4M added.
  • The largest IDEAYA Biosciences seller in Q3 2021 was 5AM Venture Management, an estimated $9.34M sold.

Based on aggregated 13F filings for Q3 2021.